Dr. Reddy's Laboratories announces the first generic launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. Market
Business

Reddy’s Laboratories announces the launch of Tobramycin Inhalation Solution, USP in the U.S. Market

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Tobramycin Inhalation Solution, USP a therapeutic equivalent generic version of […]